Loading clinical trials...
Loading clinical trials...
Home-based Behavioral Therapy (HBT): Psychosocial Intervention Project for Early Adolescents With Pre- or Early Substance Use Disorder: Phase II
This study will compare two programs to see if they are helpful in preventing the use of substances in adolescents with attention deficit-hyperactivity disorder (ADHD), oppositional defiant disorder (ODD), or conduct disorder (CD). One of the programs involves working with adolescents and their parent(s) in their home. The other program involves working with adolescents and their parent(s) in an office setting.
In this study phase, 36 patients with a disruptive behavior disorder (DBD - i.e., attention deficit-hyperactivity disorder, oppositional defiant disorder, conduct disorder) and use or abuse of one or more substances will be randomly assigned to treatment using either a standard treatment for DBDs in this age group or the newly developed HBT treatment. Treatment outcomes for the 24 patients assigned to receive HBT will then be compared to outcomes for the 12 patients assigned to receive standard DBD treatment. Specific aims of Phase II include: 1. finalizing the HBT treatment manual and measures of treatment fidelity, therapist competence, and treatment satisfaction; 2. generating estimates of treatment effect sizes for substance use, disruptive behavior, and functional status outcomes, as pilot data for a larger efficacy study, and 3. comparing treatment satisfaction for the two treatment groups. We hypothesize that HBT will lead to significantly lower rates of disruptive behaviors, substance use, and SUDs than with standard treatment, as well as greater concomitant improvements in impairment.
Age
11 - 14 years
Sex
ALL
Healthy Volunteers
No
Youth and Family Research Program
Pittsburgh, Pennsylvania, United States
Start Date
January 1, 2006
Primary Completion Date
May 1, 2009
Completion Date
May 1, 2009
Last Updated
May 26, 2011
36
ESTIMATED participants
Adolescent Skills Parent Management Parent-Adol Negotiation
BEHAVIORAL
Treatment as Usual
BEHAVIORAL
Lead Sponsor
University of Pittsburgh
NCT07456631
NCT06831123
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07189442